Literature DB >> 25452542

Decision making and referral from primary care for possible lung and colorectal cancer: a qualitative study of patients' experiences.

Jon Banks1, Fiona M Walter2, Nicola Hall3, Katie Mills2, William Hamilton4, Katrina M Turner1.   

Abstract

BACKGROUND: The challenge for GPs when assessing whether to refer a patient for cancer investigation is that many cancer symptoms are also caused by benign self-limiting illness. UK National Institute for Health and Care Excellence (NICE) referral guidelines emphasise that the patient should be involved in the decision-making process and be informed of the reasons for referral. Research to date, however, has not examined the extent to which these guidelines are borne out in practice. AIM: To assess the degree to which patients are involved in the decision to be referred for investigation for symptoms associated with cancer and their understanding of the referral. DESIGN AND
SETTING: Qualitative interview study of patients referred to secondary care for symptoms suspicious of lung and colorectal cancer. Patients were recruited from two regions of England using maximum variation sampling.
METHOD: Transcribed interviews were analysed thematically.
RESULTS: The analysis was based on 34 patient interviews. Patients in both symptom pathways reported little involvement in the decision to be referred for investigation. This tended to be accompanied by a patient expectation for referral, however, to explain ongoing and un-resolving symptoms. It was also found that reasons for referral tended to be couched in non-specific terms rather than cancer investigation, even when the patient was on a cancer-specific pathway.
CONCLUSION: GPs should consider a more overt discussion with patients when referring them for further investigation of symptoms suspicious of cancer. This would align clinical practice with NICE guidelines and encourage more open discussion between GPs and primary care patients around cancer. © British Journal of General Practice 2014.

Entities:  

Keywords:  colorectal cancer; decision making; lung cancer; primary health care; qualitative research; referral and consultation

Mesh:

Year:  2014        PMID: 25452542      PMCID: PMC4240150          DOI: 10.3399/bjgp14X682849

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  13 in total

1.  Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study.

Authors:  Peter Vedsted; Frede Olesen
Journal:  Br J Gen Pract       Date:  2011-08       Impact factor: 5.386

2.  Patient pressure for referral for headache: a qualitative study of GPs' referral behaviour.

Authors:  Myfanwy Morgan; Linda Jenkins; Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

Review 3.  Positive predictive values of ≥5% in primary care for cancer: systematic review.

Authors:  Mark Shapley; Gemma Mansell; Joanne L Jordan; Kelvin P Jordan
Journal:  Br J Gen Pract       Date:  2010-09       Impact factor: 5.386

Review 4.  Cancer diagnosis in primary care.

Authors:  William Hamilton
Journal:  Br J Gen Pract       Date:  2010-02       Impact factor: 5.386

5.  Women's preferences for and views on decision-making for diagnostic tests.

Authors:  Heather M Davey; Jacqueline Lim; Phyllis N Butow; Alexandra L Barratt; Sally Redman
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

Review 6.  Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making.

Authors:  Natalie Joseph-Williams; Glyn Elwyn; Adrian Edwards
Journal:  Patient Educ Couns       Date:  2013-11-09

7.  Eliciting symptoms interpreted as normal by patients with early-stage lung cancer: could GP elicitation of normalised symptoms reduce delay in diagnosis? Cross-sectional interview study.

Authors:  Lucy Brindle; Catherine Pope; Jessica Corner; Geraldine Leydon; Anindo Banerjee
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

Review 8.  The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis.

Authors:  Fiona Walter; Andrew Webster; Suzanne Scott; Jon Emery
Journal:  J Health Serv Res Policy       Date:  2011-10-18

9.  Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer.

Authors:  V L Allgar; R D Neal
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

10.  Patients' experiences of referral for colorectal cancer.

Authors:  Shane W Pascoe; Craig Veitch; Lisa J Crossland; Justin J Beilby; Allan Spigelman; John Stubbs; Mark F Harris
Journal:  BMC Fam Pract       Date:  2013-08-26       Impact factor: 2.497

View more
  11 in total

1.  Patient worry and concern associated with referral on the two-week suspected head and neck pathway.

Authors:  Catherine E P Rowlands; Peter James; Derek Lowe; Simon N Rogers
Journal:  Br Dent J       Date:  2022-07-05       Impact factor: 2.727

2.  Typologies in GPs' referral practice.

Authors:  Olav Thorsen; Miriam Hartveit; Jan Olav Johannessen; Lars Fosse; Geir Egil Eide; Jörn Schulz; Anders Bærheim
Journal:  BMC Fam Pract       Date:  2016-07-18       Impact factor: 2.497

3.  Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study.

Authors:  Fiona M Walter; Jon D Emery; Silvia Mendonca; Nicola Hall; Helen C Morris; Katie Mills; Christina Dobson; Clare Bankhead; Margaret Johnson; Gary A Abel; Matthew D Rutter; William Hamilton; Greg P Rubin
Journal:  Br J Cancer       Date:  2016-08-04       Impact factor: 7.640

4.  Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries.

Authors:  M L Tørring; P Murchie; W Hamilton; P Vedsted; M Esteva; M Lautrup; M Winget; G Rubin
Journal:  Br J Cancer       Date:  2017-08-08       Impact factor: 7.640

5.  The diagnostic pathway of Parkinson's disease: a cross-sectional survey study of factors influencing patient dissatisfaction.

Authors:  Annette O A Plouvier; Tim C Olde Hartman; Olga A de Bont; Sjoerd Maandag; Bastiaan R Bloem; Chris van Weel; Antoine L M Lagro-Janssen
Journal:  BMC Fam Pract       Date:  2017-08-25       Impact factor: 2.497

6.  Cancer suspicion in general practice, urgent referral, and time to diagnosis: a population-based GP survey nested within a feasibility study using information technology to flag-up patients with symptoms of colorectal cancer.

Authors:  Elaine Kidney; Sheila Greenfield; Lindy Berkman; George Dowswell; William Hamilton; Sally Wood; Tom Marshall
Journal:  BJGP Open       Date:  2017-10-04

7.  Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: A qualitative interview study.

Authors:  Yvonne Cunningham; Sally Wyke; Kevin G Blyth; Douglas Rigg; Sara Macdonald; Una Macleod; Stephen Harrow; Kathryn A Robb; Katriina L Whitaker
Journal:  Psychooncology       Date:  2019-02-12       Impact factor: 3.894

8.  Persistent Unilateral Sore Throat: Should It Be Included in the 2-Week Wait Referral Criteria by NICE.

Authors:  Ahmed Allam; Hazem Nijim
Journal:  Int J Otolaryngol       Date:  2019-05-05

9.  Using willingness-to-pay to establish patient preferences for cancer testing in primary care.

Authors:  Sandra Hollinghurst; Jonathan Banks; Lin Bigwood; Fiona M Walter; Willie Hamilton; Tim J Peters
Journal:  BMC Med Inform Decis Mak       Date:  2016-08-09       Impact factor: 2.796

10.  Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study.

Authors:  Hayley C Prout; Allan Barham; Emily Bongard; Rhiannon Tudor-Edwards; Gareth Griffiths; Willie Hamilton; Emily Harrop; Kerry Hood; Chris N Hurt; Rosie Nelson; Catherine Porter; Kirsty Roberts; Trevor Rogers; Emma Thomas-Jones; Angela Tod; Seow Tien Yeo; Richard D Neal; Annmarie Nelson
Journal:  Trials       Date:  2018-08-04       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.